Registered entities
ATHIRA PHARMA, INC.
Reg. No. 453368487United States
Innovation
12 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 1,052 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 9 |
| 2025 | 10 |
| 2026 | 1 |
Social engagement
Social engagement: 7.4K social following, 9 posts in the last 12 months — around the industry typical range.
Investor mix
24 investors on record; lead investors include Alzheimer's Drug Discovery, Dolby Family Ventures, Perceptive Advisors, Array.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 42% |
| Private equity | 1 | 4% |
| Accelerator & incubator | 1 | 4% |
| Bank & private debt | 2 | 8% |
| Other / undisclosed | 10 | 42% |
Recent activity
17 Jun 2026
Event
BIO International Convention 2026
10 Jun 2026
Event
BIO International Convention 2026
27 May 2026
Event
5th Annual ALS Drug Development Summit